__________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________

Meeting date: 7 July 2021

 

Chairperson:  Professor Paul Matthews (Imperial College London) 
Faculty: Professor Frederik Barkhof (University College London) and Dr Declan Chard (University College London)

In this webinar, Professor Paul Matthews, Professor Frederik Barkhof and Dr Declan Chard discuss the use of magnetisation transfer ratio (MTR) as an emerging tool in MS clinical research. They explain what MTR is, why MTR is used and considerations for its interpretation. 

Following the presentations, Professor Paul Matthews facilitates a Q&A session. 

This non-promotional webinar was organised and funded by Novartis Pharmaceuticals UK Ltd and is intended for UK healthcare professionals.  

Rate this content: 
No votes yet
UK | November 2021 | 170154
×

Ask Speakers

×

Medical Information Request

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Novartis via uk.patientsafety@novartis.com or online through the pharmacovigilance intake (PVI) tool at www.report.novartis.com
If you have a question about the product, please contact Medical Information on 01276 698370 or by email at medinfo.uk@novartis.com